Skip to content

Clinical efficacy of Low-Level Red-Light on young children with myopic amblyopia

Clinical efficacy of Low-Level Red-Light on young children with myopic amblyopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074908
Enrollment
Unknown
Registered
2023-08-20
Start date
2023-08-20
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopic amblyopia

Interventions

Low intensity red light group:Low intensity red light
control group:Single focus frame glasses

Sponsors

Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 8 Years

Inclusion criteria

Inclusion criteria: 1) Written informed consent signed by the child and legal guardian has been obtained. 2) Children aged 4 to 8 years (including threshold). 3) After cycloplegia, the computer optometry test shows that the equivalent spherical lens power of both eyes is = -0.50D, or those who meet the clinical diagnosis of myopic amblyopia and exclude pathological myopia. 4) Astigmatism = 2.50D 5) Those who voluntarily give up other treatment methods during the study period

Exclusion criteria

Exclusion criteria: If the subject meets any of the following criteria, they cannot be enrolled: 1) Subjects who may suffer from eye diseases that affect vision or refractive errors, such as lens damage diseases such as cataracts, glaucoma, macular degeneration, keratopathy, uveitis, retinal detachment, severe vitreous opacity, etc. 2) Patients with photosensitivity, Tourette syndrome, ADHD, and psoriasis. 3) The duration of the afterimage exceeds 6 minutes. 4) Systemic diseases: History of immune system diseases, central nervous system diseases, Down syndrome, asthma, severe cardiopulmonary function, and severe liver and kidney dysfunction. 5) Having manifest strabismus or any other pathological changes or acute inflammatory diseases of the eyes in both eyes. 6) Have used myopia control therapy within 3 months, including medication such as atropine; Instrument treatment: For patients with multifocal soft lenses, multifocal hard lenses, functional frame glasses, amblyopia treatment equipment, etc.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;Axial length;Sphere equivalent after cycloplegia;

Secondary

MeasureTime frame
Uncorrected visual acuity;Optical Coherence mography;Adverse event;

Countries

China

Contacts

Public ContactWang Xiaojuan

Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University

153803468@qq.com+86 158 5226 0552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026